Insider buying · SEC Form 4

Insider Buying — Aug 18, 2026

Company insiders — CEOs, CFOs, directors and 10% owners — buying their own company's stock on the open market: every purchase of $250K or more from the previous day's Form 4 filings, largest first, with an AI summary of the day.

8insider buys
$9.02Mbought in total
7companies
4by CEOs, CFOs and other chiefs
BORRlargest: $2.19M

Every qualifying buy, largest first

StockInsiderValueSharesAvg priceTypeFiled
BORRBorr Drilling LtdTor Olav TroimDirector$2.19M500,000$4.39AddedAug 17, 2026
Form 4 ↗
Purchase via Drew Holdings Ltd (Drew Trust, non-discretionary trust of which Troim is beneficiary). Bought at $4.3868/sh avg. Now $4.50 (+2.5%). Post-buy indirect stake: 28,685,941 shares. Follows weak Q2 earnings — classic Troim dip-buy pattern.
ONONOn Holding AGBernhard OlivierCo-CEO / Executive Officer$1.99M65,000$30.67AddedAug 17, 2026
Form 4 ↗
Open-market purchase at $30.6737 weighted avg (range $30.57–$30.78), Aug 14. Now $31.31 (+2.1%). Cluster: Co-CEO Coppetti made identical 65K-share purchase same day — combined $4.0M dual-CEO buy.
ONONOn Holding AGCaspar Felix CoppettiCo-CEO / Executive Officer$1.99M65,000$30.67AddedAug 17, 2026
Form 4 ↗
Open-market purchase at $30.6737 weighted avg (range $30.57–$30.78), Aug 14. Now $31.31 (+2.1%). Post-buy holdings: 2,440,855 shares direct. Cluster buy with Co-CEO Bernhard Olivier.
KURAKura Oncology, Inc.Troy Edward WilsonPresident and CEO$1.11M100,000$11.12AddedAug 17, 2026
Form 4 ↗
Purchase via One Fish Two Fish Revocable Trust at $11.12 weighted avg (range $10.87–$11.31). Now $11.28 (+1.4%). Post-buy total holdings across all accounts: 1,114,650 shares. CEO buying biotech at multi-month lows.
MLABMesa Laboratories IncSiddhartha KadiaPresident and CEO$800K7,093$112.80AddedAug 17, 2026
Form 4 ↗
Private transaction from Board Chair John Sullivan at $112.80/sh (not open-market). Purchased via Anjou Parekh Lifetime Access Trust (spouse as trustee). Now $107.64 (-4.6% under water). Note: transaction code P but privately negotiated.
NRGVEnergy Vault Holdings, Inc.Dylan HixonDirector$320K85,518$3.74AddedAug 17, 2026
Form 4 ↗
Three separate purchases Aug 14: 26,845 sh via Casimir R. Hixon Trust @ $3.733 ($100,229), 26,809 sh via Soren A. Hixon Trust @ $3.733 ($100,084), 31,864 sh by son @ $3.75 ($119,490). Now $3.82 (+2.1%). Reporting person disclaims beneficial ownership of trust/son shares except to pecuniary interest.
REZIResideo Technologies IncJoshua Peter FosterSVP, GC & Corp Sec$315K15,317$20.58AddedAug 17, 2026
Form 4 ↗
Open-market purchase at $20.57 avg on Aug 14. Now $20.64 (+0.3%). Senior legal officer buying near 52-week range lows in smart-home / connected-devices space.
ENHAEnhanced Group IncApeiron Investment Group Ltd10%+ Owner$296K150,000$1.97AddedAug 17, 2026
Form 4 ↗
Purchase at $1.97/sh avg on Aug 14. Now $1.71 (-13.2% under water). Apeiron is a 10%+ institutional owner adding to position; micro-cap with wide bid/ask spread.

AIThe day in insider buying

SEC Form 4 Insider Scan — August 18, 2026

Scanned the last 24 hours of EDGAR Form 4 filings. 8 qualifying buys (≥ $250K, transaction type P) totalling $9.0M.

Headline filings

  • BORR — Tor Olav Troim (Director) bought 500,000 shares ≈ $2.2M at $4.39 avg; now $4.50 (+2.5% since buy). (filing)
  • ONON — Bernhard Olivier (Co-CEO / Executive Officer) bought 65,000 shares ≈ $2.0M at $30.67 avg; now $31.31 (+2.1% since buy). Cluster: fellow Co-CEO Coppetti made an identical 65,000-share purchase the same day — combined ~$4.0M dual-CEO buy. (filing)
  • ONON — Caspar Felix Coppetti (Co-CEO / Executive Officer) bought 65,000 shares ≈ $2.0M at $30.67 avg; now $31.31 (+2.1% since buy). (filing)
  • KURA — Troy Edward Wilson (President & CEO) bought 100,000 shares ≈ $1.1M at $11.12 avg (via trust, range $10.87–$11.31); now $11.28 (+1.4% since buy). (filing)
  • MLAB — Siddhartha Kadia (President & CEO) bought 7,093 shares ≈ $800K at $112.80 avg (private transaction from Board Chair); now $107.64 (-4.6% since buy). (filing)
  • NRGV — Dylan Hixon (Director) bought 85,518 shares ≈ $320K at ~$3.74 avg (via family trusts + son); now $3.82 (+2.1% since buy). (filing)
  • REZI — Joshua Peter Foster (SVP, GC & Corp Sec) bought 15,317 shares ≈ $315K at $20.57 avg; now $20.64 (+0.3% since buy). (filing)
  • ENHA — Apeiron Investment Group Ltd (10%+ Owner) bought 150,000 shares ≈ $296K at $1.97 avg; now $1.71 (-13.2% since buy).

Notes

ONON cluster buy — strongest signal of the day: Both co-CEOs of On Holding AG (Bernhard Olivier and Caspar Felix Coppetti) each bought 65,000 shares at $30.67 on August 14 — a coordinated $4.0M combined purchase by the two top executives. On Holding has pulled back from highs amid macro uncertainty; this dual-CEO conviction buy at the same price is a high-quality insider signal.

BORR dip buy: Director Tor Olav Troim (via Drew Holdings/Drew Trust) added 500K shares to an already massive ~28.7M-share indirect stake in Borr Drilling, following what media described as a weak Q2 quarter. Troim has a long track record of buying BORR dips aggressively.

KURA CEO conviction: CEO Troy Wilson bought 100K shares at ~$11 through a family revocable trust, placing $1.1M in the biotech at current levels. Kura Oncology's oral RAS inhibitor pipeline has been a volatile story — this is a sizable, meaningful CEO commitment.

MLAB private buy, note caveats: Mesa Labs CEO Kadia purchased shares directly from departing Board Chair John Sullivan in a negotiated private transaction — code P but not an open-market purchase. Still a meaningful alignment signal; shares are now 4.6% below his cost basis.

ENHA underwater: Apeiron's 150K-share purchase at $1.97 is already -13.2% in the money; Enhanced Group is a micro-cap name with wide spreads — monitor for further accumulation or position exits.

Sectors represented: Offshore drilling / energy (BORR, NRGV), Sportswear/footwear (ONON), Oncology biotech (KURA), Life science tools (MLAB), Smart home / connected devices (REZI), Consumer-tech (ENHA).

Most-bought stocks, last 30 days

  • SCTX $56.3M · 3 buys, 3 insidersScribe Therapeutics Inc.
  • COE $56.2M · 7 buys, 2 insiders51Talk Online Education Group
  • MPLT $15.3M · 1 buyMapLight Therapeutics, Inc.
  • FLUT $11.8M · 1 buyFlutter Entertainment plc
  • LBRX $10.0M · 1 buyLB Pharmaceuticals Inc.
  • BSX $9.00M · 1 buyBoston Scientific Corp
  • PBLS $6.92M · 1 buyParabilis Medicines, Inc.
  • APMD $5.00M · 1 buyApnimed, Inc.
  • BLSM $5.00M · 1 buyBlossomHill Therapeutics, Inc.
  • GSHD $4.49M · 3 buysGoosehead Insurance, Inc.
  • BORR $4.39M · 2 buysBorr Drilling Ltd
  • ONON $3.99M · 2 buys, 2 insidersOn Holding AG
  • TXO $3.58M · 2 buysTXO Partners, L.P.
  • LILA $2.90M · 1 buyLiberty Latin America Ltd.
  • ARTV $2.58M · 1 buyArtiva Biotherapeutics, Inc.
  • LTGO $2.52M · 1 buyLatigo Biotherapeutics, Inc.
  • APTV $2.50M · 1 buyAptiv PLC
  • CSGP $2.49M · 1 buyCoStar Group, Inc.
  • ACI $2.41M · 2 buys, 2 insidersAlbertsons Companies, Inc.
  • NATR $2.32M · 1 buyNature's Sunshine Products, Inc.

All scans

Source: insiders' SEC Form 4 filings — open-market purchases (transaction code P) of $250K or more filed in the previous day. Insiders must file within two business days of a trade, so a purchase can be a day or two older than its filing. Average price = value ÷ shares. Insiders buy for many reasons and a purchase is no guarantee the shares will rise. The summaries are written by AI as a research aid — not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Insider Buying reads the SEC Form 4 filings insiders file after trading their own company's stock and lists every open-market purchase of $250K or more — who bought, their role, how much and at what average price. Insiders sell for many reasons, but they usually buy for one: they think the shares are worth more. It is free, and a new scan is posted every trading day. How to read insider buying →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartOpen in the Stocks tab

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.